Calcium blocking properties of piprofurol

Area of Science:

• Pharmacology
• Cardiovascular Science
• Medicinal Chemistry

Background:

• Piprofurol is a novel benzofuran chalcone derivative.
• Calcium channel blockers are crucial in managing cardiovascular diseases.

Purpose of the Study:

• To investigate the calcium antagonistic and anti-ischaemic properties of piprofurol.
• To characterize the pharmacological profile of piprofurol in vitro and in vivo.

Main Methods:

• In vitro studies using isolated rat aorta, dog coronary artery, and rabbit basilar artery preparations to assess vascular smooth muscle relaxation.
• Electrophysiological studies on guinea-pig papillary muscle to evaluate effects on cardiac action potentials and contractility.
• In vivo experiments in anesthetized dogs to assess coronary blood flow, heart rate, and ST-segment changes following coronary artery occlusion.

Main Results:

• Piprofurol demonstrated concentration-dependent inhibition of calcium-induced contractions in vascular smooth muscle with potent relaxant effects.
• In cardiac muscle, piprofurol reduced the rate of rise of slow action potentials and exhibited a negative inotropic effect.
• In vivo, piprofurol increased coronary blood flow, decreased heart rate, and reduced ST-segment elevation, indicating anti-ischaemic activity.

Conclusions:

• Piprofurol possesses significant calcium antagonistic properties in both vascular and cardiac tissues.
• The compound shows a favorable therapeutic ratio, suggesting potential for clinical application in cardiovascular conditions.
• Piprofurol's demonstrated anti-ischaemic effects warrant further investigation for its therapeutic utility.